Adaptafusion topical delivery platform for scalp aging

Overview

AdaptaFusion represents a cutting-edge solution in scalp care, leveraging the unique properties of protocatechuic acid (PCA) to combat the chronic inflammation associated with scalp aging. This platform is formulated to enhance penetration and stability of active ingredients, ensuring effective delivery to the scalp and follicles. The product is compliant with cosmetic regulations across the US, EU, and Canada, making it ready for global market entry. Its vegan formulation, featuring fermented EGCG, underscores its innovative approach to scalp longevity.

Technical specifications

Key components:

• Protocatechuic acid (PCA): Acts as a penetration enhancer and anti-inflammatory agent.
• Fermented EGCG: Provides additional anti-inflammatory and epigenetic modulation benefits.
• Zinc pyrithione, panthenol, and allantoin: Support scalp health and enhance delivery efficacy.
• Propanediol-based system: Ensures deep follicular penetration.

The formulation operates at a pH of 5.0-5.5, maintaining ingredient stability and compatibility with scalp physiology. The non-provisional patent application secures IP protection for the AdaptaFusion platform.

Technology readiness level

Currently, AdaptaFusion is at TRL 3-4, with ongoing efforts to validate its efficacy in scalp-specific applications. A structured plan involving pilot trials and co-development engagements is in place to advance this technology towards commercialization. The proposed phased approach ensures comprehensive testing and optimization, paving the way for successful market introduction.